Testing effectiveness (Phase 2)Study completedNCT01331746What this trial is testingProof-of-concept (PoC) Study of APD515Who this might be right forXerostomia in Advanced Cancer Patients Acacia Pharma Ltd 32
Very early researchEnded earlyNCT03578432What this trial is testingEverolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation TherapyWho this might be right forSalivary Gland DysfunctionXerostomiaHead and Neck Cancer University of Arizona 2
Large-scale testing (Phase 3)Study completedNCT00101582What this trial is testingPalifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck CancerWho this might be right forMucositisSolid TumorsStomatitis+2 more Swedish Orphan Biovitrum 188
Testing effectiveness (Phase 2)Ended earlyNCT00352118What this trial is testingCombination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Masonic Cancer Center, University of Minnesota 4
Early research (Phase 1)Looking for participantsNCT03816345What this trial is testingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOWho this might be right forAutoimmune DiseaseCrohn DiseaseDermatomyositis+11 more National Cancer Institute (NCI) 300
Not applicableLooking for participantsNCT06287294What this trial is testingAn Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced CancerWho this might be right forTaste, AlteredXerostomiaNeoplasms Our Lady's Hospice and Care Services 120
Testing effectiveness (Phase 2)Ended earlyNCT01682031What this trial is testingSelenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyWho this might be right forChemotherapeutic Agent ToxicityMucositisRadiation Toxicity+13 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00095927What this trial is testingRandomized Amifostine For SCCHNWho this might be right forChemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more Dana-Farber Cancer Institute 58